{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05164",
      "entity_text" : "MPO",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0688" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:10116" ]
    }
  },
  "verbose_text" : "Differently from what has been shown by other authors who evaluated the efficacy of infliximab in experimental models of TNBS induced colitis, in this study we identified greater reduction of MPO levels in infliximab treated animals especially when higher concentrations were used (10 mg/kg/weeks).",
  "reading_complete" : "2020-08-05T19:16:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:15:28Z",
  "trigger" : "levels",
  "evidence" : [ "MPO levels" ],
  "pmc_id" : "6912843",
  "score" : 0
}